Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

References for PMC Articles for PubMed (Select 21731576)

1.

Adenosine kinase as a target for therapeutic antisense strategies in epilepsy.

Theofilas P, Brar S, Stewart KA, Shen HY, Sandau US, Poulsen D, Boison D.

Epilepsia. 2011 Mar;52(3):589-601. doi: 10.1111/j.1528-1167.2010.02947.x. Epub 2011 Jan 28.

2.

Acute encephalopathy with inflammation-mediated status epilepticus.

Nabbout R, Vezzani A, Dulac O, Chiron C.

Lancet Neurol. 2011 Jan;10(1):99-108. doi: 10.1016/S1474-4422(10)70214-3. Review.

PMID:
21163447
3.

Methylxanthines, seizures, and excitotoxicity.

Boison D.

Handb Exp Pharmacol. 2011;(200):251-66. doi: 10.1007/978-3-642-13443-2_9. Review.

4.

Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress.

Kelley SA, Kossoff EH.

Dev Med Child Neurol. 2010 Nov;52(11):988-93. doi: 10.1111/j.1469-8749.2010.03744.x. Epub 2010 Aug 16. Review.

PMID:
20722665
5.

In search of models of pharmacoresistant epilepsy.

Wahab A, Albus K, Gabriel S, Heinemann U.

Epilepsia. 2010 Jul;51 Suppl 3:154-9. doi: 10.1111/j.1528-1167.2010.02632.x. Review.

PMID:
20618423
6.

Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity.

Marchi N, Teng Q, Ghosh C, Fan Q, Nguyen MT, Desai NK, Bawa H, Rasmussen P, Masaryk TK, Janigro D.

Brain Res. 2010 Sep 24;1353:176-86. doi: 10.1016/j.brainres.2010.06.051. Epub 2010 Jun 27.

7.

Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?

Potschka H.

Epilepsia. 2010 Aug;51(8):1333-47. doi: 10.1111/j.1528-1167.2010.02585.x. Epub 2010 Apr 30. Review.

PMID:
20477844
8.

Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels.

Kawamura M Jr, Ruskin DN, Masino SA.

J Neurosci. 2010 Mar 17;30(11):3886-95. doi: 10.1523/JNEUROSCI.0055-10.2010.

9.

Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.

Iyer AM, Zurolo E, Boer K, Baayen JC, Giangaspero F, Arcella A, Di Gennaro GC, Esposito V, Spliet WG, van Rijen PC, Troost D, Gorter JA, Aronica E.

Neuroscience. 2010 May 19;167(3):929-45. doi: 10.1016/j.neuroscience.2010.02.047. Epub 2010 Feb 26.

PMID:
20219643
10.

Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy.

Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, van Vliet EA, Baayen JC, Gorter JA.

Eur J Neurosci. 2010 Mar;31(6):1100-7. doi: 10.1111/j.1460-9568.2010.07122.x. Epub 2010 Feb 26.

PMID:
20214679
11.

Tuning and fine-tuning of synapses with adenosine.

Sebastião AM, Ribeiro JA.

Curr Neuropharmacol. 2009 Sep;7(3):180-94. doi: 10.2174/157015909789152128.

12.

Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis.

Qureshi IA, Mehler MF.

Neurobiol Dis. 2010 Jul;39(1):53-60. doi: 10.1016/j.nbd.2010.02.005. Epub 2010 Feb 24. Review.

13.

Network dynamics during development of pharmacologically induced epileptic seizures in rats in vivo.

Cymerblit-Sabba A, Schiller Y.

J Neurosci. 2010 Feb 3;30(5):1619-30. doi: 10.1523/JNEUROSCI.5078-09.2010.

14.

Key factors in the discovery and development of new antiepileptic drugs.

Bialer M, White HS.

Nat Rev Drug Discov. 2010 Jan;9(1):68-82. doi: 10.1038/nrd2997. Review.

PMID:
20043029
15.

Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet.

Ruskin DN, Kawamura M, Masino SA.

PLoS One. 2009 Dec 23;4(12):e8349. doi: 10.1371/journal.pone.0008349.

16.

A nonsynaptic mechanism underlying interictal discharges in human epileptic neocortex.

Roopun AK, Simonotto JD, Pierce ML, Jenkins A, Nicholson C, Schofield IS, Whittaker RG, Kaiser M, Whittington MA, Traub RD, Cunningham MO.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):338-43. doi: 10.1073/pnas.0912652107. Epub 2009 Dec 4.

17.

Management of the patient with medically refractory epilepsy.

Granata T, Marchi N, Carlton E, Ghosh C, Gonzalez-Martinez J, Alexopoulos AV, Janigro D.

Expert Rev Neurother. 2009 Dec;9(12):1791-802. doi: 10.1586/ern.09.114. Review.

18.

Astrocyte dysfunction in epilepsy.

Seifert G, Carmignoto G, Steinhäuser C.

Brain Res Rev. 2010 May;63(1-2):212-21. doi: 10.1016/j.brainresrev.2009.10.004. Epub 2009 Oct 31. Review.

PMID:
19883685
19.

Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.

Urdinguio RG, Sanchez-Mut JV, Esteller M.

Lancet Neurol. 2009 Nov;8(11):1056-72. doi: 10.1016/S1474-4422(09)70262-5. Review.

PMID:
19833297
20.

Delayed time to first remission identifies poor long-term drug response of childhood-onset epilepsy: a prospective population-based study.

Sillanpää M, Schmidt D.

Epilepsy Behav. 2009 Nov;16(3):507-11. doi: 10.1016/j.yebeh.2009.08.029. Epub 2009 Sep 29.

PMID:
19793683
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk